Skip to main content

Month: July 2021

Soaring to New Heights

SFIO Goes into Real Estate and Property Development with $100M Projects in the Pipeline HAMILTON, New Zealand, July 14, 2021 (GLOBE NEWSWIRE) — Smokefree Innotec, Inc. [SFIO] is pleased to announce that it has recently entered into a Memorandum of Agreement [MOA] with AG Architects 2019 Limited [AG Architects] that is set to be a 100% subsidiary of Agrokings, Inc., a wholly-owned company of SFIO, following the reverse merger between Agrokings, Inc. and SFIO. SFIO intends to get a share of the lucrative real estate industry, and this year poses a promising year for AG Architects as it bags over NZD 55 million worth of construction projects to be accomplished within the year. The fund coming from investors is aimed to produce a 113% return for the company. Apart from its current projects, AG Architects has approximately NZD 100...

Continue reading

Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that it has entered into definitive agreements with several healthcare-focused institutional and accredited investors for the purchase and sale of 21,357,744 shares of the Company’s common stock (or common stock equivalents) and warrants to purchase up to an aggregate of 10,678,872 shares of the Company’s common stock, at a purchase price of $1.311 per share of common stock (or common stock equivalent) and associated warrant, in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is...

Continue reading

LeMaitre Announces Pricing of Public Offering of Common Stock

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less underwriting discounts and commissions. Jefferies...

Continue reading

Imara Announces Pricing of Public Offering

BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced the pricing of its previously announced underwritten public offering of shares of its common stock at a public offering price of $6.00 per share, for gross proceeds of $50 million, before underwriting discounts and commissions and offering expenses payable by the Company. The offering is expected to close on July 16, 2021, subject to customary closing conditions. All shares are being offered by the Company. In addition, the Company has granted the underwriters an option for a period of 30 days to purchase up to $7.5 million of additional shares of its...

Continue reading

Prospect Park Capital to Complete CSE Listing and Voluntary TSXV De-Listing

VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) — Prospect Park Capital Corp. (the “Company”) ‎‎(TSXV:PPK), a public investment issuer, is pleased to announce that it has received approval to list its common shares (the “Common Shares”) on the Canadian Securities Exchange (the “CSE“), and will be voluntarily delisting its Common Shares from the TSX Venture Exchange (the “TSXV“). To ensure continued trading of the Common Shares, the Company anticipates that the Common Shares will commence trading on the CSE at the open of markets on July 15, 2021 and intends to arrange for the delisting of the Common Shares from the TSXV at the close of markets on or about July 15, 2021. The Company’s trading symbol “PPK” will remain the same. Management is of the view that listing the common shares on the...

Continue reading

Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock

HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of $42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. Jefferies, SVB Leerink, Guggenheim Securities and Cantor are acting as the joint book-running managers for the offering. LifeSci Capital LLC and H.C. Wainwright & Co. are acting as co-lead managers for the offering. The Company expects to receive gross proceeds from the offering, excluding the exercise of the underwriters’ option, if any,...

Continue reading

Itaú Corpbanca shareholders approved a capital increase for Ch$830 billion

“This is good news, because it will allow us to converge to CET1 capitalization ratios around 10% ‒in line with the main local banks‒, boost our growth and digital transformation,” said at the end of the shareholders’ meeting, Itaú Corpbanca’s CEO, Gabriel Moura SANTIAGO, Chile, July 13, 2021 (GLOBE NEWSWIRE) — ITAÚ CORPBANCA (NYSE: ITCB; SSE: ITAUCORP) today announced that the Extraordinary Shareholders’ Meeting held on this date agreed to approve the Ch$830 billion capital increase proposed by the board of directors, with the aim of supporting the bank’s future growth and digital transformation. With this capital increase, the bank will obtain new funding to support its growth and digital transformation, at the same time that it will achieve capital ratios in line with main peers in the local industry,...

Continue reading

June Quarterly Report Investor Webinar and Conference Call

PERTH, Western Australia, July 14, 2021 (GLOBE NEWSWIRE) — Perseus Mining Limited (“Perseus” or the “Company”) (TSX & ASX: PRU) is hosting an investor webinar and conference call to discuss its June 2021 Quarterly Report, which is anticipated for release around 8:30am AEST on Wednesday July 21, 2021. Call Details Australia: Wednesday July 21, 2021 (Perth – 7:00am) (Sydney/Melbourne – 9:00am) Canada: Tuesday July 20, 2021 (Toronto – 7:00pm) (Vancouver – 4:00pm) UK: Wednesday July 21, 2021 (London – 12:00am) Register for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_Ux1Lx159QtyB7_HmqunJsg After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the below numbers and enter the Webinar...

Continue reading

NuVista Energy Ltd. Announces Issuance of $230 Million of Senior Unsecured Notes and Call of Existing 2023 Notes

THIS PRESS RELEASE IS NOT FOR PUBLICATION OR DISSEMINATION IN THE UNITED STATES, FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, July 13, 2021 (GLOBE NEWSWIRE) — NuVista Energy Ltd. (“NuVista” or the “Company”) (TSX:NVA) is pleased to announce today that it has entered into an underwriting agreement to sell, on a private placement basis, $230 million aggregate principal amount of 7.875% senior unsecured notes due July 23, 2026 (the “Notes”), which was increased from the previously announced offering of $200 million. The Notes will be issued at $989.89 expressed as a price per $1,000.00 principal amount under a new trust indenture, and will be direct senior unsecured obligations of NuVista ranking equal with all other present and future senior unsecured...

Continue reading

Suncor Energy releases 2021 Report on Sustainability and Climate Report

Hear from Mark Little, President & CEO, on our approach to sustainability.All financial figures are in Canadian dollars CALGARY, Alberta, July 13, 2021 (GLOBE NEWSWIRE) — Continuing more than 25 years of sustainability reporting, Suncor released its 2021 Report on Sustainability and Climate Report today. The reports share the company’s 2020 environmental, social and governance (ESG) performance and highlight key points of progress in early 2021. Earlier this year, the company shared its updated strategy which focuses on increasing shareholder returns while accelerating its greenhouse gas (GHG) emissions reduction targets, growing its business in low GHG fuels, electricity, and hydrogen, sustaining and optimizing its base business and transforming its GHG footprint to be a net-zero company by 2050 – all...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.